
Funding Progress
$150,000.00 raised on CataCap toward a $600,000 goal
3 donors have supported this
Invest: Minimum ($25000)
You give to CataCap, a 501(c)(3). You recommend where it's invested; CataCap makes the investment, and any returns are credited to your charitable account to recommend again.
About CytoCT Co.
CytoCT is building a low-cost, point-of-care, AI-driven, cartridge-based platform for disease detection anywhere by anyone. No lab required. The initial cartridge will be used for Tuberculosis detection and contact tracing. The next cartridge will be for HIV and immune profile. Future cartridges will assess Malaria.
Themes & SDGs Supported

Mission and Vision
To make the diagnostic power of cytometry available to everyone, everywhere.
Investment Terms
To view Terms/Materials, you must have a CataCap account and be logged in. Access to full materials is available to Donor/Investors with an active CataCap balance.
If you do not have an active balance, you may contact the company or fund directly using the “Questions about this investment?” link, or email [email protected] for assistance.
Investment Materials
To view Materials/Terms, you must have a CataCap account and be logged in. Access to full materials is available to Donor/Investors with an active CataCap balance.
If you do not have an active balance, you may contact the company or fund directly using the “Questions about this investment?” link, or email [email protected] for assistance.
Funding Progress
$150,000.00 raised on CataCap toward a $600,000 goal
3 donors have supported this
Donate to invest
Invest: Minimum ($25000)
You give to CataCap, a 501(c)(3). You recommend where it's invested; CataCap makes the investment, and any returns are credited to your charitable account to recommend again.

